{"nct_id":"NCT00633789","title":"Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types","status":"COMPLETED","status_verified_date":"2015-09","start_date":"2008-06","start_date_type":null,"primary_completion_date":"2012-02","primary_completion_date_type":"ACTUAL","completion_date":"2012-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}